Multinationals and financial institutions face a complex journey from shaping a deal to closing it, to managing post-transaction integration.
Transactions can have a strategically transformative impact, but they can be high-risk – as well as high-reward. More than 70% of transactions fail to deliver the value envisaged. Experience and efficiency are essential in coming out on top, as is picking the right partner.
Baker McKenzie can guide you through every step of the transaction process, from strategy, due diligence deal structuring and financing, to weighing tax, competition, employment and regulatory considerations, to all aspects of post-acquisition integration.
We combine global market knowledge with local cultural nuance and industry specialism. We utilize innovative technologies, underpinned by sound judgment and years of experience, to lead our clients through complex, multinational deals, every day. We are a transactional powerhouse.
What do others say about us?
*Source: Refinitiv deal volumes
Baker McKenzie strengthens Banking & Finance practice with hire of Anthony Kay
Anthony Kay brings significant experience and client relationships in the EMEA-wide syndicated lending and direct lending markets.
View press release
Baker McKenzie continues to grow its Banking & Finance practice with an additional partner hire
Based in Sydney, Holly is a corporate trust and agency practitioner specializing in capital markets and banking, advising corporate trustees and agents, and working with clients across Asia Pacific.
View press release
Michael F. DeFrancoPartner
+ 1 312 861 8230 Email
Richard G. BluntPartner
+ 44 20 7919 1842 Email
+ 44 20 7919 1195 Email
+ 44 20 7919 1818 Email
Adam B. FarlowPartner
+ 44 20 7919 1514 Email
Juan Bernardo (JB) GarcíaPartner
+ 52 81 8399 1344 Email
+ 44 20 7919 1757 Email
José Antonio MoránPartner
+ 1 312 861 2829 Email
Healthtech and Biotech M&A
The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.
Tech M&A Outlook
After a pullback in tech M&A in 2022, and with IPO markets sluggish, dealmakers expect an uptick in M&A activity in 2023.
The M&A landscape has shifted this year to take account of more strategic concerns. Companies are focused on supply chain disruption, inflation and geopolitical unrest, creating interesting opportunities for buyers.
Digital Assets M&A
How do tech acquisitions differ from other deals? How do you choose your targets? And what are the guests’ biggest tips?
SPACs in Healthtech
While SPACs offer opportunities for healthtech companies, the road to a de-SPAC process can be complex and perilous.